QbD principles and strategic thinking can reduce the time required to optimize formulation.
Ronald D. Snee
Advertisement
Ronald D. Snee, PhD, is president of Snee Associates, 10 Creek Crossing, Newark, DE, 19711 tel: 610.213.5595, fax 302.369.9971.
Articles by Ronald D. Snee
Control charts that are properly constructed and maintained prevent false out-of-control signals and provide a useful method for monitoring a process.
Advertisement
Latest Updated Articles
Reducing False Out-of-Control SignalsPublished: August 1st 2014 | Updated:
Speeding Up Formulation DevelopmentPublished: September 1st 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
2
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
3
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
4
PharmTech Weekly News Roundup — Week of October 27, 2025
5
